Medium/long term effect of travoprost on the intraocular pressure (IOP) in normal tension glaucoma (NTG)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN53835788

Enrollment

Registered

2005-09-30

Start date

2004-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases: Glaucoma Eye Diseases Glaucoma

Interventions

Prospective randomised controlled observer blinded clinical trial.

Eligibility

Inclusion criteria

Inclusion criteria: Adults with normal tension glaucoma.

Exclusion criteria

Exclusion criteria: 1. Patients on systemic medication 2. Patients who have undergone intraocular eye surgery

Design outcomes

Primary

Measure	Time frame
The primary clinical outcome measure is diurnal IOP at follow up phasing: the major comparison is to be made between the IOP for travoprost treatment group and for the non-treatment group.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026